Literature DB >> 15836967

Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

Diane C Zelman1, Ellen Dukes, Nancy Brandenburg, Alan Bostrom, Mugdha Gore.   

Abstract

This study identified discrete categories of pain severity in a sample of patients with painful diabetic peripheral neuropathy (DPN), through derivation of cut-points on a 0-10 scale of pain severity (Brief Pain Inventory-DPN, BPI-DPN). Subjects were participants in a burden of illness survey (N=255). Serlin and colleagues' method establishing cut-points for cancer pain was adapted, considering all possible cut-points between 4 and 8. Optimal cut-points were those that created three pain severity categories producing maximum between-category differences on the seven BPI-DPN Interference items, using MANOVA. Cut-points of 4 and 7 optimally classified the sample for both Worst Pain and Average Pain, creating categories of mild, 0-3; moderate, 4-6; severe, 7 and higher (Hotelling's T(2)=22.95 and 16.20 for Worst and Average Pain, P<0.0001). Mean BPI-DPN Interference was 2.1 (SD=2.1), 4.9 (SD=1.9) and 7.4 (SD=1.6) for the mild, moderate and severe pain categories. Patients in the three categories differed significantly on patient-rated outcomes (Medical Outcomes Study Short Form-12v2 Mental and Physical Component Summaries and EuroQOL utility score), and on DPN-related healthcare visits (P<0.001). The labels 'mild, moderate and severe' Worst and Average Pain corresponded with patients' ratings of their pain using a verbal rating scale. This research shows that three categories of DPN pain severity can be identified based on interference with daily function, and that these categories are associated with patient outcomes and medical utilization.

Entities:  

Mesh:

Year:  2005        PMID: 15836967     DOI: 10.1016/j.pain.2005.01.028

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  66 in total

1.  [What does pain intensity mean from the patient perspective? : A qualitative study on the patient perspective of pain intensity as an outcome parameter in treatment evaluation and on the interpretability of pain intensity measurements].

Authors:  K Neustadt; S Deckert; C Kopkow; A Preißler; B Bosse; C Funke; L Jacobi; P Mattenklodt; B Nagel; P Seidel; R Sittl; E Steffen; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2017-12       Impact factor: 1.107

2.  Creating meaningful cut-scores for Neuro-QOL measures of fatigue, physical functioning, and sleep disturbance using standard setting with patients and providers.

Authors:  Karon F Cook; David E Victorson; David Cella; Benjamin D Schalet; Deborah Miller
Journal:  Qual Life Res       Date:  2014-08-23       Impact factor: 4.147

3.  Does Physiological Stress Slow Down Wound Healing in Patients With Diabetes?

Authors:  Javad Razjouyan; Gurtej Singh Grewal; Talal K Talal; David G Armstrong; Joseph L Mills; Bijan Najafi
Journal:  J Diabetes Sci Technol       Date:  2017-04-24

4.  Ambulation and complications related to assistive devices after spinal cord injury.

Authors:  Lee L Saunders; James S Krause; Nicole D DiPiro; Sara Kraft; Sandra Brotherton
Journal:  J Spinal Cord Med       Date:  2013-04-13       Impact factor: 1.985

5.  Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment.

Authors:  David Cella; Seung Choi; Sofia Garcia; Karon F Cook; Sarah Rosenbloom; Jin-Shei Lai; Donna Surges Tatum; Richard Gershon
Journal:  Qual Life Res       Date:  2014-06-18       Impact factor: 4.147

6.  Cortical disinhibition occurs in chronic neuropathic, but not in chronic nociceptive pain.

Authors:  Peter Schwenkreis; Andrea Scherens; Anne-Kathrin Rönnau; Oliver Höffken; Martin Tegenthoff; Christoph Maier
Journal:  BMC Neurosci       Date:  2010-06-11       Impact factor: 3.288

7.  Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain.

Authors:  Cinzia Brunelli; Ernesto Zecca; Cinzia Martini; Tiziana Campa; Elena Fagnoni; Michela Bagnasco; Luigi Lanata; Augusto Caraceni
Journal:  Health Qual Life Outcomes       Date:  2010-04-22       Impact factor: 3.186

8.  Toward characterization and definition of fibromyalgia severity.

Authors:  Stuart Silverman; Alesia Sadosky; Chris Evans; Yating Yeh; Jose Ma J Alvir; Gergana Zlateva
Journal:  BMC Musculoskelet Disord       Date:  2010-04-08       Impact factor: 2.362

9.  Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults.

Authors:  Mark Wallace; Barbara Evans; Sandra Woods; Robin Mogg; Lei Zhang; Adam C Finnefrock; Dietmar Rabussay; Michael Fons; John Mallee; Devan Mehrotra; Florian Schödel; Luwy Musey
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

10.  Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial.

Authors:  Muriel Viala-Danten; Susan Martin; Isabelle Guillemin; Ron D Hays
Journal:  Health Qual Life Outcomes       Date:  2008-12-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.